Beni Haruka Sweet Potato (Ipomoea batatas)

Beni Haruka sweet potato (Ipomoea batatas) contains high concentrations of anthocyanins and phenolic compounds that provide anti-inflammatory effects. These bioactive compounds suppress inflammatory cytokine production including IL-6, TNF-alpha, and iNOS through inhibition of NF-κB signaling pathways.

Origin & History

Beni Haruka is a light-yellow-fleshed cultivar of the sweet potato (*Ipomoea batatas*) developed through Japanese breeding programs. It is cultivated as a staple food and has been used in mutagenesis research involving heavy-ion beam irradiation to study tuber formation. The tubers are typically consumed whole or processed into ethanol extracts for research purposes.

Historical & Cultural Context

The research dossier does not specify any historical use in traditional medicine for the Beni Haruka cultivar itself. It is a modern Japanese cultivar consumed daily as a staple food, while the general sweet potato species (*Ipomoea batatas*) has a long history of consumption in Japan and other regions.

Health Benefits

[{"benefit": "Exhibits Anti-Inflammatory Properties: In preclinical cell studies, Beni Haruka tuber extracts suppressed the production of inflammatory markers IL-6, TNF, and iNOS in response to LPS stimulation. Evidence quality: Preliminary (in-vitro).", "citation": 5}, {"benefit": "May Support Liver Health: In a pilot RCT on a related purple-fleshed sweet potato (not Beni Haruka), an anthocyanin-rich beverage significantly reduced liver enzymes AST, ALT, and GGT versus placebo over 8 weeks. Evidence quality: Moderate (indirect evidence from a related cultivar).", "citation": 1}, {"benefit": "May Improve Vitamin A Status: In an RCT involving a related beta-carotene-rich orange-fleshed sweet potato (not Beni Haruka), daily consumption by children for 53 days significantly improved vitamin A status. Evidence quality: Moderate (indirect evidence from a related cultivar).", "citation": 3}, {"benefit": "Activates Nrf2 Antioxidant Pathway: Preclinical research shows that tuber extracts activate the Nrf2 pathway in macrophages, a key mechanism for managing oxidative stress and inflammation. Evidence quality: Preliminary (in-vitro).", "citation": 5}, {"benefit": "Provides Carotenoids: The pale yellow flesh of Beni Haruka is due to its carotenoid content, which is regulated by a zeaxanthin epoxidase (ZEP) paralog. Evidence quality: Compositional Analysis.", "citation": 4}]

How It Works

Beni Haruka sweet potato's anthocyanins and phenolic compounds inhibit NF-κB transcriptional activity, preventing the upregulation of inflammatory genes. These compounds specifically suppress the production of pro-inflammatory cytokines IL-6, TNF-alpha, and inducible nitric oxide synthase (iNOS) in response to lipopolysaccharide stimulation. The anti-inflammatory effects occur through direct antioxidant activity and modulation of cellular signaling cascades involved in immune responses.

Scientific Research

No clinical trials or meta-analyses have been conducted specifically on the Beni Haruka cultivar. However, a pilot RCT on a related purple-fleshed sweet potato beverage (PMID: 27530473) demonstrated benefits for liver enzymes, and a separate RCT on an orange-fleshed sweet potato (PMID: 15883432) showed improved vitamin A status in children.

Clinical Summary

Current evidence for Beni Haruka sweet potato is limited to preliminary in-vitro cell culture studies demonstrating anti-inflammatory properties. These studies show significant suppression of inflammatory markers when cells are pre-treated with tuber extracts before LPS challenge. No human clinical trials have been conducted to evaluate safety, efficacy, or optimal dosing protocols. The evidence quality remains preliminary and requires validation through animal studies and human trials before therapeutic claims can be substantiated.

Nutritional Profile

Beni Haruka sweet potato (Ipomoea batatas) is a Japanese orange-fleshed cultivar notable for its exceptionally high sugar content (Brix value ~16–20° after curing, among the highest of Japanese sweet potato varieties) and distinctive nutritional composition. Per 100g of raw edible portion, approximate values are: Energy 126–132 kcal; Carbohydrates 30–33g (predominantly starch 15–18g, which converts significantly to maltose upon baking via beta-amylase activity, yielding ~10–14g maltose in baked form); Dietary fiber 2.8–3.5g (mix of soluble pectin ~0.5–0.8g and insoluble cellulose/hemicellulose); Sugars (raw) 6–9g, increasing dramatically to 18–22g post-baking due to enzymatic starch conversion; Protein 1.2–1.6g (containing all essential amino acids in modest quantities); Fat 0.1–0.2g (negligible). Key micronutrients per 100g: Potassium 480–550mg (notable, supports electrolyte balance); Vitamin C 25–35mg (moderate bioavailability; partially degraded by heat, ~30–50% loss upon baking); Beta-carotene (provitamin A) 500–800 µg (orange flesh pigment; fat-soluble, bioavailability enhanced by co-consumption with dietary fat, estimated conversion to retinol activity ~1/12 by weight); Vitamin B6 (pyridoxine) 0.25–0.35mg; Folate 22–28 µg; Manganese 0.25–0.35mg; Copper 0.15–0.20mg; Magnesium 22–28mg; Calcium 28–35mg (low bioavailability due to oxalate content); Iron 0.5–0.8mg (non-heme, moderate bioavailability); Zinc 0.3–0.4mg. Bioactive compounds: Chlorogenic acids and other hydroxycinnamic acid derivatives (caffeic acid, 3,4-dicaffeoylquinic acid) are the primary polyphenols in orange-fleshed Beni Haruka, estimated at 100–300mg/100g fresh weight — notably lower in anthocyanins compared to purple-fleshed sweet potato varieties; Sporamins (storage proteins with trypsin inhibitor activity) 1–2% of dry weight; Resin glycosides present in small quantities in skin; Beta-carotene and other carotenoids (lutein, zeaxanthin in minor amounts). Fiber bioavailability note: Resistant starch content is higher in raw versus cooked form; cooking significantly reduces resistant starch. Curing (storage at 13–15°C post-harvest) increases sweetness and alters starch-to-sugar ratios. The glycemic index of baked Beni Haruka is estimated high (~70–85) due to maltose surge from baking, though the fiber content moderates postprandial glucose response relative to GI value alone.

Preparation & Dosage

No clinically validated dosage for Beni Haruka has been established. A study on a related purple-fleshed sweet potato used 531 mg of anthocyanins daily (delivered in three 125 ml bottles) for 8 weeks. Preclinical cell studies have used tuber extracts at a concentration of 10 µg/mL to observe anti-inflammatory effects. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Sulforaphane, Vitamin E, Astaxanthin

Safety & Interactions

Beni Haruka sweet potato is generally recognized as safe when consumed as a food, with no known serious adverse effects reported. As a dietary supplement extract, potential interactions with anti-inflammatory medications or immunosuppressive drugs are theoretically possible but not documented. Individuals with diabetes should monitor blood glucose levels due to natural carbohydrate content. Safety during pregnancy and lactation has not been established through clinical studies, so pregnant women should consult healthcare providers before supplementation.